Results

Total Results: 2,942 records

Showing results for "description".

2661. Return on Investment Tool (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/f1_combo_returnoninvestment.pdf
      January 01, 2013 - Actions NOTES Effects Identified A Comparison Period B Implementation Period Net Change (Description … system, the ROI team retrospectively identified each way the practice saved money (for a detailed description … BWH Used To Conduct an ROI Analysis for CPOE Implementation Element of Analysis Measure(s) or Values Description

2662. Section 5, Table 3 (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-5-table-3.pdf
      August 01, 2014 - Section 5, Table 3 Table 3: Evidence for Obtaining a Blood Culture for Treatment of Children with Sepsis Syndrome Type of Evidence Key Findings Level of Evidence (USPSTF Ranking*) Citations Clinical guidelines Pediatric considerations in severe sepsis: Empiric antibiotics should be administered with…

2663. Neonatal Intensive Care All-Condition Readmissions with Gestational Age Reported (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-fullreport.pdf
      June 01, 2019 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample … Description and evaluation of a program for the early discharge of infants from a neonatal intensive … Measure Description 1.D. Measure Owner 1.E. National Quality Forum (NQF) ID (if applicable) 1.F.

2664. CHIPRA 212 Table 4 (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-table-4.pdf
      May 24, 2016 - CHIPRA 212 Table 4 Table 4: Evidence Supporting ICS at Discharge from an Emergency Department TYPE OF EVIDENCE KEY FINDINGS LEVEL OF EVIDENCE (USPSTF RANKING*) CITATION(S) Clinical guidelines Consider initiating ICS therapy for patients who did not use an ICS prior to the hospital admission. If the d…

2665. Reporting of Supplemental CAHPS Data Regarding Availability of Treatment or Counseling Services for Children on Medicaid: Final Report (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
      October 01, 2019 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Throughout this measure description, we will continue to use the CAHPS terminology of “treatment or … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample

2666. Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults: Report (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
      December 01, 2019 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample … NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences

2667. CHIPRA 201: Section 5, Table 3 (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-asthma-section-5-table-3.pdf
      February 19, 2016 - CHIPRA 201: Section 5, Table 3 Table 3: Evidence in Support of Education for Proper Use of New Medication Delivery Devices for Children with Asthma TYPE OF EVIDENCE KEY FINDINGS LEVEL OF EVIDENCE (USPSTF RANKING*) CITATION(S) Clinical guidelines The Expert Panel recommends that clinicians d…

2668. Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-fullreport.pdf
      February 01, 2019 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample

2669. ADHD Chronic Care Follow Up (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-145-fullreport.pdf
      July 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample … The PMCoE Expert Workgroup reviewed the ADHD Chronic Care Follow-up measure description, specifications … Measure Description 1.D. Measure Owner 1.E. National Quality Forum (NQF) ID (if applicable) 1.F.

2670. Timely Temperatures for All Low Birth Weight Neonates (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-116-fullreport.pdf
      November 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … Research Evidence Research evidence should include a brief description of the evidence base for valid … The ratings of the panel along and a brief description of methodology can be found in the supporting … Include results of all tests of validity and reliability, including description(s) of the study 11 … Measure Description 1.D. Measure Owner 1.E. National Quality Forum (NQF) ID (if applicable) 1.F.

2671. Initial Baseline Screen of Nutritional Status for Every Patient Within 24 Hours of Pediatric Intensive Care Unit (PICU) Admission (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-199-fullreport.pdf
      November 01, 2017 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample … See description of the CPQSC participating hospitals in the Supporting Documents (Section 6-A, CPQSC … Comment: “I think a validated nutrition screening tool is needed or a better description of what the

2672. Initial Risk Assessment for Immobility-Related Pressuer Ulcer Within 24 Hours of Pediatric Intensive Care Unit (PICU) Admission (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-203-fullreport.pdf
      April 10, 2017 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Stewarded by the Centers for Medicare & Medicaid Services, this measure’s description includes: “Pressure … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample … A description of the CPQSC participating hospitals is presented in the Supporting Documents.

2673. Debrief Example - Implementation Guide | Agency for Healthcare Research and Quality
      www.innovations.ahrq.gov/hai/tools/ambulatory-surgery/sections/implementation/implementation-guide/app-k.html
      May 01, 2017 -  -  Physician Assistant   –  -  Infection Preventionist Slide 4: Data Description

2674. Appropriate Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-fullreport.pdf
      April 01, 2018 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample … Abstractors participated in onsite training during which the measure was discussed at length to include the description

2675. Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-fullreport.pdf
      August 01, 2017 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample … Abstractors participated in onsite training during which the measure was discussed in length to include the description

2676. Use of Multiple Concurrent Antipsychotics in Children (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
      May 01, 2018 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample

2677. Timeliness of Antibiotic Prophylaxis for Children With Sickle Cell Disease (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-135-fullreport.pdf
      February 01, 2017 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample

2678. Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
      May 01, 2018 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample

2679. CHIPRA 234: Access to Outpatient Dental Care for Children (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-234-fullreport.pdf
      June 17, 2014 - Measure Description Please provide a non-technical description of the measure that conveys what it measures … Research Evidence Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study sample

2680. Applying the AHRQ Quality Indicators to Hospital Data (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/b1_combo_applyingqis.pdf
      March 01, 2016 - Formulas and Uses for the Four Types of QI Rates Type of Rate Brief Description Way To Use It Observed